Senkyunolide H reverses depression-induced breast cancer progression by regulating CXCR2

Yingchao Wu(Dalian Ocean University), Qian Zuo, Qianjun Chen(Shenzhen Luohu People's Hospital), Liushan Chen(Guangzhou University of Chinese Medicine), Congwen Yang(Chongqing Medical University), Jieting Chen(Guangzhou University of Chinese Medicine), Yuqi Liang(Guangxi Medical University), Jiaqi Cui(China Pharmaceutical University), Junfeng Huang(Guangzhou University of Chinese Medicine)
Natural Products and Bioprospecting
August 21, 2025
10.1007/s13659-025-00543-6
Cited by 2

Related Papers

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
|JAMA|2020|229
Association between serum leptin levels and breast cancer risk
|Medicine|2018|103
Educational Data Mining Techniques for Student Performance Prediction: Method Review and Comparison Analysis
|Frontiers in Psychology|2021|103
Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3/p53/NRF2 axis in colorectal cancer cells
|Acta Biochimica et Biophysica Sinica|2023|98
International experience of carbon neutrality and prospects of key technologies: Lessons for China
|Petroleum Science|2023|96